Novel glucagon-like peptide-1 (GLP-1) analog (Val8)GLP-1 results in significant improvements of glucose tolerance and pancreatic beta-cell function after 3-week daily administration in obese diabetic (ob/ob) mice.

Brian Green, P.R. Flatt, K. Lavery, N. Irwin, F.P.M. O'Harte, Patrick Harriott, Brett Greer, C.J. Bailey

Research output: Contribution to journalArticle

44 Citations (Scopus)
Original languageEnglish
Pages (from-to)914-921
Number of pages8
JournalJournal of Pharmacology and Experimental Therapeutics
Volume318(2)
Issue number2
DOIs
Publication statusPublished - Apr 2006

ASJC Scopus subject areas

  • Pharmacology

Cite this